It has been reported that the serum concentration of ApoA1 in breast cancer, colorectal cancer, and pancreatic cancer was lower than that of the control group, which was considered to be a serum marker for detecting carcinoma [23-25]. The gene discussed is APOA1; the disease is breast carcinoma.